MedPath

Alterations of Gut Microbiome, Function, and Its Intervention After Defunctioning Ileostomy

Early Phase 1
Recruiting
Conditions
Ileostomy - Stoma
Rectal Cancer
Microbial Disease
Intestinal Functional Disorder
Interventions
Drug: MIYAIRI 588
Registration Number
NCT05759741
Lead Sponsor
Huashan Hospital
Brief Summary

This study focused on the alterations of gut microbiome and function during defunctioning ileostomy, and observed the effects of probiotic intervention on intestinal microbiome and function. The investigators looked forward to find the specific intestinal maladjusted flora from this work, which could provide a new scheme for the subsequent treatment of the damaged intestinal function and the reduction of the incidence of postoperative complication.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  1. Patients with primary rectal cancer received total mesolectal resection combined with defunctioning ileostomy.
  2. Patients voluntarily sign informed consent.
Exclusion Criteria
  1. Disease progression or death after surgery.
  2. Patients with inflammatory bowl disease.
  3. Patients need to be on antibiotics/other probiotics for a long time.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MIYAIRI 588 groupMIYAIRI 5884 tablets of MIYAIRI 588 were inserted into distal ileostomy once a week for 6 months.
Primary Outcome Measures
NameTimeMethod
Wexner incontinence score1 year

Assess defecation function,the score range is 0-20, 0 is normal, 20 is complete incontinence

Secondary Outcome Measures
NameTimeMethod
fecal incontinence quality-of-life scale1 year

The Fecal Incontinence Quality of Life Scale is composed of a total of 29 items; these items form four scales: Lifestyle (10 items), Coping/Behavior (9 items), Depression/Self-Perception (7 items), and Embarrassment (3 items). The score of each scale is 1-4 points. The higher the score, the worse the quality of life.

Rate of postoperative complications1 month after operation

Such as anastomotic leakage, operative death, intestinal obstruction, intestinal infection,etc.

Trial Locations

Locations (1)

Huashan hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath